37
Views
0
CrossRef citations to date
0
Altmetric

REFERENCES

  • Bansal M, Rastogi S, Vineeth NS. Influence of periodontal disease on systemic disease: Inversion of a paradigm: A review. J Med Life 2013. 6(2): pp. 126-30.
  • World Health Organization. WHO definition of health. 1948.
  • Hunter W. Oral Sepsis as a Cause of Disease. Br Med J 1900. 2(2065): pp. 215-6.
  • Dreizen S. Oral indications of the deficiency states. Postgrad Med 1971. 49(1): pp. 97-102.
  • Williams RC, Offenbacher S. Periodontal medicine: The emergence of a new branch of periodontology. Periodontol 2000, 2000. 23: pp. 9-12.
  • Terezhalmy GT. Proceedings of the American Academy of Oral Medicine. The medical history. Special Committee for Clinical Investigation — report no. 1. J Oral Med 1982. 37(4): pp. 141-3.
  • Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: Diagnosis and treatment. Clin Microbiol Rev 2001. 14(4): pp. 727-52, table of contents.
  • National Institute of Dental and Craniofacial Research. Periodontal Disease in Adults (age 20-64) (seniors over 65). 2014.
  • Lawrence B, Glascoe A, McIntosh C, Brown A. Periodontal Disease and Systemic Health for Medical Students. 2013.
  • Brogden KA, Guthmiller JM, eds. Chapter 8: Periodontal Diseases in Polymicrobial Diseases. ASM Press Herndon, Va., 2002.
  • Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent Jr. RL. Microbial complexes in subgingival plaque. J Clin Periodontol 1998. 25(2): pp. 134-44.
  • Kim J, Amar S. Periodontal disease and systemic conditions: A bidirectional relationship. Odontology 2006. 94(1): pp. 10-21.
  • Cotsapas C, Hafler DA. Immune-mediated disease genetics: The shared basis of pathogenesis. Trends Immunol 2013. 34(1): pp. 22-6.
  • Esmaili N, Chams-Davatchi C, Valikhani M, Daneshpazhooh, Toosi S, et al. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris. Arch Iran Med 2014;17:626-8.
  • Cheng MH, Anderson MS. Insights into type 1 diabetes from the autoimmune polyendocrine syndromes. Curr Opin Endocrinol Diabetes Obes 2013. 20(4): pp. 271-8.
  • World Health Organization. Diabetes Progamme: About Diabetes. 2014.
  • Chapple IL, Genco R. Diabetes and periodontal diseases: Consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol 2013. 40 suppl. 14: pp. S106-12.
  • American Diabetes Association: Statistics About Diabetes. National Diabetes Statistics Report. 2014.
  • National Institute for Health and Care Excellence. Clinical Guideline 66: Type 2 Diabetes. 2008.
  • Gjymishka A, Coman RM, Brusko TM, Glover SC. Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and type 1 diabetes. Immunotherapy 2013. 5(12): pp. 1357-66.
  • Centers for Disease Control and Prevention. National Diabetes Fact Sheet. Diabetes Public Health Resource, 2011.
  • National Diabetes Information Clearinghouse (NDIC): Service of National Institutes of Diabetes and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services, Insulin Resistance and Prediabetes.
  • Santos Tunes R, Foss-Freitas MC, Nogueira-Filho Gda R. Impact of periodontitis on the diabetes-related inflammatory status. J Can Dent Assoc 2010. 76: p. a35.
  • Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010. 375(9733): pp. 2215-22.
  • O’Gara PT, Kushner FG, Ascheim DD, Casey Jr. DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013. 127(4): pp. e362-425.
  • Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes — systematic overview of prospective observational studies. Diabetologia 2005. 48(12): pp. 2460-9.
  • Lamster IB, Lalla E, Borgnakke WS, Taylor GW. The relationship between oral health and diabetes mellitus. J Am Dent Assoc 2008. 139 suppl. pp. 19S-24S.
  • Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993. 16(1): pp. 329-34.
  • Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000 2007. 44: pp. 127-53.
  • Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the U.S. adult population. Community Dent Oral Epidemiol 2002. 30(3): pp. 182-92.
  • Thorstensson H, Kuylenstierna J, Hugoson A. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol 1996. 23: pp. 194-202.
  • Saremi A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005. 28: pp. 27-32.
  • Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004. 27(3): pp. 813-23.
  • Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004. 25(1): pp. 4-7.
  • Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study. Lancet 1999. 353(9165): pp. 1649-52.
  • Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003. 278(46): pp. 45777-84.
  • Salvi GE, Yalda B, Collins JG, Jones BH, Smith FW, Arnold RR, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulindependent diabetes mellitus patients. J Periodontol 1997. 68(2): pp. 127-35.
  • Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res 1981. 60(3): pp. 729-30.
  • Stanko P, Izakovicova Holla L. Bidirectional association between diabetes mellitus and inflammatory periodontal disease. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014. 158(1): pp. 35-8.
  • Naguib G, Al-Mashat H, Desta T, Graves DT. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 2004. 123(1): pp. 87-92.
  • Mealey, BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol 2006. 77(8): pp. 1289-303.
  • Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol 2005. 76(11 Suppl): pp. 2106-15.
  • D’Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, et al. Periodontitis and systemic inflammation: Control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004. 83(2): pp. 156-60.
  • Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factoralpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001. 72(6): pp. 774-8.
  • Tunali M, Ataoglu T, Celik I. Apoptosis: An underlying factor for accelerated periodontal disease associated with diabetes in rats. Clin Oral Investig 2014. 18(7): pp. 1825-33.
  • Engebretson S, Kocher T. Evidence that periodontal treatment improves diabetes outcomes: A systematic review and meta-analysis. J Periodontol 2013. 84(4 suppl.): pp. S153-69.
  • Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: The role of tumor necrosis factor-alpha in a two-way relationship. J Periodontol 2003. 74(1): pp. 97-102.
  • Mealey BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes 2008. 15(2): pp. 135-41.
  • Llambes F, Silvestre FJ, Hernández-Mijares A, Guiha R, Caffesse R. The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus. Clin Oral Investig 2008. 12(4): pp. 337-43.
  • Arheiam A, Omar S. Dental caries experience and periodontal treatment needs of 10- to 15-year-old children with type 1 diabetes mellitus. Int Dent J 2014. 64(3): pp. 150-4.
  • Bascones-Martinez A, Matesanz-Perez P, Escribano-Bermejo M, González-Moles MÁ, Bascones-Ilundain J, Meurman JH. Periodontal disease and diabetes — review of the literature. Med Oral Patol Oral Cir Bucal 2011. 16(6): pp. e722-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.